Journal of Experimental Medicine

The Journal of Experimental Medicine is a peer-reviewed academic journal published by the Rockefeller University Press that publishes research papers and commentaries on the physiological, pathological, and molecular mechanisms that encompass the host response to disease. The journal prioritizes studies on intact organisms and has made a commitment to publishing studies on human subjects. Topics covered include immunology, inflammation, infectious disease, hematopoiesisas, cancer, stem cells and vascular biology. The JEM is second highest (based on impact factor) among the journals that publish basic research articles from all fields of biomedicine. Among all biomedical journals (specialized or nonspecialized) JEM stands among the top 10. The JEM was founded in 1896 at the Johns Hopkins School of Medicine by William H. Welch, the school’s founder and also the first president of the Board of Scientific Directors of the Rockefeller Institute (since re-named the Rockefeller University). From its inception, Welch edited the journal by himself—even editing manuscripts while attending baseball games—and he eventually found that it placed too heavy a burden on his time. By March 1902, the

Publisher
Rockefeller University Press
Country
United States
History
1896–present
Impact factor
14.776 (2010)
Some content from Wikipedia, licensed under CC BY-SA

New agent might control breast-cancer growth and spread

A new study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) suggests that an unusual ...

Apr 22, 2013
popularity not rated yet | comments 0 | with audio podcast

Pathological thickening of the cardiac wall halted

The heart responds to the increased stress caused by chronically raised blood pressure, for example, by thickening its wall muscle. In the late stage of this condition, a risk of heart failure arises. Scientists from the ...

Mar 26, 2013
popularity 5 / 5 (1) | comments 0 | with audio podcast

Breakthrough in battle against leukemia

Scientists at Griffith University's Institute for Glycomics and The Saban Research Institute of Children's Hospital Los Angeles have discovered a critical weakness in leukaemic cells, which may pave the way to new treatments.

Mar 13, 2013
popularity 5 / 5 (5) | comments 0

Tumor blood vessels prevent the spread of cancer cells

A lack of the protein endoglin in the blood vessels of tumour-bearing mice enables the spread of daughter tumours, according to researchers at Karolinska Institutet and Lund University in Sweden in a study published in the ...

Feb 11, 2013
popularity not rated yet | comments 0

The skin aging regulator

Despite progress in regenerative medicine, with age, the skin loses its properties in an irreversible manner. The ATIP-Avenir team "Epidermal homeostasis and tumorigenesis" directed by Chloé Féral, an Inserm ...

Jan 22, 2013
popularity 5 / 5 (2) | comments 0

Surviving sepsis with LECT2

Failure to launch an adequate immune response may be at the root of septic shock, according to a study published in The Journal of Experimental Medicine on December 17th.

Dec 17, 2012
popularity not rated yet | comments 0

Gene knockout stops immune cell development

(Medical Xpress)—Researchers at the Wellcome Trust Sanger Institute have identified the key gene in ensuring that our immune defences develop infection-fighting cells. No cells of the adaptive immune system ...

Dec 11, 2012
popularity 5 / 5 (3) | comments 0 | with audio podcast